主要收入构成
报告期:2023-12-31
主营产品构成(百万) |
名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
凝血耗材 |
19.41% |
53.47 |
12.00% |
19.17 |
64.15% |
0.40% |
凝血试剂 |
57.46% |
158.30 |
20.16% |
42.12 |
73.39% |
1.21% |
凝血仪器 |
15.49% |
42.68 |
34.35% |
34.05 |
20.22% |
2.61% |
其他(补充) |
0.18% |
0.50 |
-15.78% |
0.27 |
45.81% |
-2.17% |
其他耗材 |
0.00% |
0.00 |
92.86% |
0.00 |
64.71% |
-0.92% |
其他仪器 |
1.61% |
4.44 |
51.78% |
1.79 |
59.80% |
4.75% |
血流变耗材 |
1.84% |
5.07 |
26.21% |
1.00 |
80.25% |
2.52% |
血流变试剂 |
0.49% |
1.35 |
8.28% |
0.13 |
90.04% |
3.17% |
血流变仪器 |
3.51% |
9.67 |
10.13% |
3.69 |
61.86% |
0.31% |
总计 |
275.49 |
行业收入构成(百万) |
名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
其他(补充) |
0.18% |
0.50 |
-15.78% |
0.27 |
45.81% |
-2.17% |
医药制造业 |
99.82% |
274.99 |
20.49% |
101.95 |
62.93% |
0.55% |
总计 |
275.49 |
地区收入构成(百万) |
名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
东北地区 |
4.59% |
12.65 |
21.67% |
4.90 |
61.24% |
-0.95% |
海外地区 |
3.98% |
10.96 |
-- |
6.18 |
43.60% |
-- |
华北地区 |
12.32% |
33.94 |
35.21% |
14.14 |
58.33% |
-2.50% |
华东地区 |
26.14% |
72.02 |
15.95% |
25.15 |
65.08% |
1.03% |
华南地区 |
9.34% |
25.72 |
16.68% |
8.23 |
67.99% |
5.16% |
华中地区 |
19.71% |
54.31 |
20.05% |
19.49 |
64.10% |
0.54% |
其他(补充) |
0.18% |
0.50 |
-15.78% |
0.27 |
45.81% |
-2.17% |
西北地区 |
3.06% |
8.43 |
20.30% |
3.34 |
60.40% |
-3.19% |
西南地区 |
20.68% |
56.96 |
10.13% |
20.51 |
64.00% |
1.45% |
总计 |
275.49 |